|
|
Relationship between serum level of IL-1β and MGP and cardiac valve calcification in maintenance hemodialysis patients |
CHEN Jie1 LUO Minhong2 CHEN Xingqiang1 ZHANG Meng1 FU Weiwei1 |
1.Department of Nephrology, Sanya People′s Hospital, Hainan Province, Sanya 572000, China;
2.Department of Nephrology, the Eighth Affiliated Hospital of Sun Yat-sen University, Guangdong Province, Shenzhen 518000, China |
|
|
Abstract Objective To study the relationship between serum level of interleukin-1β(IL-1β), matrix Gla protein (MGP) and cardiac valve calcification (CVC) in maintenance hemodialysis (MHD) patients. Methods Eighty patients who received MHD treatment in Sanya People′s Hospital of Hainan Province from January 2016 to November 2018 were selected as the study subjects and recorded as the observation group. Patients were divided into CVC group (n = 37) and non-CVC group (n = 43) according to whether they had CVC or not. Another 80 volunteers who received health examination during the same period were selected as the control group. The clinical data of the two groups was counted and compared. The clinical data of the subgroup in observation group was analyzed. The correlation between IL-1β, MGP and age, dialysis age was analyzed. The influencing factor of CVC in MHD patients were calculated by Logistic regression analysis. Results The ratio of CVC and the level of IL-1β in the observation group were higher those that in the control group, while the level of MGP was lower than that in the control group (P < 0.01). Age, dialysis age and IL-1β level in CVC group were higher than those in non-CVC group, while MGP level was lower than that in non-CVC group (P < 0.05 or P < 0.01). Pearson analysis showed that, IL-1β was positively correlated with age and dialysis age (r = 0.614, 0.679, all P < 0.05), while MGP was negatively correlated with age and dialysis age (r = -0.702, -0.715, all P < 0.05). Logistic regression analysis showed that, IL-1β≥160 pg/mL (OR = 1.244,95%CI: 1.021-4.820,P < 0.01), dialysis age≥30 months (OR = 1.319,95%CI: 1.039-10.512,P < 0.05) and MGP<2.55 ng/mL (OR = 1.108,95%CI: 1.007-11.287,P < 0.01) were risk factors for CVC in MHD patients. Conclusion Serum levels of IL-1β and MGP are closely related to CVC in MHD patients, and both of them and dialysis age are the influencing factors of CVC in MHD patients. Clinical monitoring of these indicator can better assess patient′s condition.
|
|
|
|
|
[1] 孙杰,尹忠诚.残余肾功能对维持性血液透析患者心脏瓣膜钙化的影响[J].中国血液净化,2018,17(3):151-155.
[2] 陈忠辉,何静.维持性血液透析患者血管钙化相关因素研究[J].蚌埠医学院学报,2016,41(9):1207-1210.
[3] 刘玺,刘芳,缪蕙,等.口服磷结合剂对老年维持性血液透析患者钙磷代谢及血管钙化的影响[J].河北医药,2018, 40(10):1509-1512.
[4] 黄丽娅,刘利萍,代正燕,等.维持性血液透析患者心血管钙化的发生率及相关因素[J].国际移植与血液净化杂志,2016,14(1):15-18.
[5] 李春芝,刘洪英,刘军肖,等.老年心脏瓣膜钙化与血清骨保护蛋白、非活性基质Gla蛋白水平的关系研究[J].临床心血管病杂志,2016,32(1):40-43.
[6] 陶睿,于书香.麻黄附子细辛汤合五苓散加味结合西医常规疗法治疗3期慢性肾脏病临床研究[J].国际中医中药杂志,2016,38(1):33-36.
[7] 李垚瑶,李梦思,郑艳丹,等.维持性血液透析患者铁代谢水平对心脏结构及功能的影响[J].临床肾脏病杂志,2018,18(1):12-16.
[8] 张菲菲,高延霞,张雪晶,等.维持性血液透析患者胎球蛋白A和炎症水平与心脏瓣膜钙化的相关性[J].临床肾脏病杂志,2015,15(3):142-146.
[9] 徐丰博,孙懿,王银娜,等.心脏瓣膜钙化预测血液透析患者冠状动脉钙化的研究[J].中国血液净化,2015,14(7):422-424.
[10] Agilli M,Aydin FN,Cayci T,et al. Fetuin-A levels and heart valve calcification in incident peritoneal dialysis patients [J]. Arch Med Res,2014,45(7):602.
[11] 张晓玲,白久旭,郝峻烽,等.维持性血液透析患者心脏瓣膜钙化与左心室肥厚相关因素分析[J].中国血液净化,2016,15(1):18-21.
[12] 刘冰,李桂花,张瑾文,等.维持性血液透析患者心脏瓣膜钙化与IL-6、hs-CRP及Fetuin-A的关系分析[J].国际泌尿系统杂志,2018,38(2):251-255.
[13] 周丽娜,陈新,朱颖玲,等.糖尿病肾脏病维持性血液透析患者心脏瓣膜钙化易发因素分析[J].临床肾脏病杂志,2016,16(9):530-534.
[14] 张磊,王志奎,马金玲,等.维持性血液透析及腹膜透析患者心脏瓣膜钙化的评估[J].实用医学杂志,2016,32(7):1130-1132.
[15] 申磊,冯雪,王莉华,等.维持性血液透析患者心脏瓣膜钙化与sclerostin之间的关系[J].临床荟萃,2018,33(10):878-882.
[16] 庞家华,赵霞,万玮,等.维持性血液透析患者的心脏瓣膜钙化发病情况[J].实用临床医药杂志,2016,20(23):185-186.
[17] 王珺,韩林子,张森,等.血清TNF-α及MGP水平与维持性血液透析患者心脏瓣膜钙化的关系[J].安徽医科大学学报,2018,53(10):1584-1588.
[18] 宋菊香,宋培,马辉,等.血液灌流联合血液透析对维持性血液透析所致心脏瓣膜钙化的影响[J].中国医药导报,2017,14(33):82-85.
[19] 李小莉,赵波.维持性血液透析患者心脏瓣膜钙化与IL-1β、hs-CRP、Fetuin-A的相关性分析[J].中国中西医结合肾病杂志,2017,18(9):810-812.
[20] Rong S,Zhao X,Jin X,et al. Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein - 2 via a mechanism involving the Wnt / beta-catenin pathway [J]. Cell Physiol Biochem,2014,34(6):2049-2060. |
|
|
|